Thursday 23 August 2018

Reuters Health Report: Bayer sees no reason to re-evaluate Monsanto legal risks

Reuters.com Newsletter

Bayer sees no reason to re-evaluate Monsanto legal risks

German drugmaker Bayer sees no reason to re-assess the legal risks from newly acquired Monsanto after the U.S. unit was ordered to pay damages in a lawsuit over alleged links between weed-killer glyphosate and cancer.

Novartis trial win lifts profile of new breast cancer drug

Novartis's efforts to tackle an elusive gene mutation behind tough-to-treat breast cancer were rewarded on Thursday, as the Swiss drugmaker said one of its investigational medicines slowed disease progression.

AstraZeneca inhaler lags GSK drug in lung disease trial

A new AstraZeneca inhaler for chronic lung disease has proved worse than a rival GlaxoSmithKline product in a clinical trial, a result AstraZeneca said was inconsistent with earlier findings.

China reports fourth African swine fever outbreak as infection spreads south

China, home to the world's largest pig herd, reported its fourth outbreak of the deadly African swine fever on Thursday, with more than 400 pigs infected as the disease entered a fourth province, fanning worries about its rapid spread.

Congo approves more experimental Ebola treatments as cases rise

Democratic Republic of Congo has approved four more experimental treatments against the deadly Ebola virus, the health ministry said as it raced to contain an outbreak in its violence-torn east.

Congo approves more experimental Ebola treatments

Democratic Republic of Congo has approved four more experimental treatments against the deadly Ebola virus, the health ministry said as it raced to contain an outbreak in its violence-torn east.

U.S. appeals court says GSK cannot be sued over generic drug suicide

A U.S. appeals court on Wednesday tossed a $3 million verdict against GlaxoSmithKline over the suicide of an attorney who took a generic version of the company's antidepressant Paxil, finding the company could not be held liable for injuries allegedly caused by a generic copy.

Pfizer, Astellas revise two cancer drug trial protocols to speed up results

Drugmakers Pfizer Inc and Astellas Pharma Inc said on Wednesday they would change protocols for two late-stage trials testing prostate cancer drug Xtandi to speed up completion.

Sport specialization tied to injuries in kids and teens

(Reuters Health) - Children and teens who specialize in one sport may be more likely to get injured than those who play a variety of sports, a new study suggests.

Venezuelan mothers-to-be head to Brazil to give birth

Expecting Venezuelan women are leaving their country due to a lack of prenatal care, medicine and diapers and giving birth across the border in Brazil, where three Venezuelan babies are born every day.

Four in 10 women with asthma may develop COPD

(Reuters Health) - Over 40 percent of women with asthma go on to develop more severe lung disease, a Canadian study suggests.

Related Videos

World in Pictures

Catholics stand by their faith after sex abuse report

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS